Linxi Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
Papers in
-
- Gastrointestinal Tumor Research and Treatment 9
-
- Metastasis and carcinoma case studies 4
- Gastric Cancer Management and Outcomes 3
- Renal cell carcinoma treatment 1
- Co-authors
- Ben Yue (2 shared papers)Gang Zhao (1 shared paper)Ran Cui (1 shared paper)Zizhen Zhang (2 shared papers)Chenlong Song (1 shared paper)Bo Ni (8 shared papers)Chun Zhuang (8 shared papers)Hui Cao (6 shared papers)
- Journals
- Molecular Cancer (1 paper)Diagnostic Pathology (1 paper)Gastric Cancer (1 paper)Cancer Medicine (1 paper)Journal of Immunology Research (1 paper)
- Partner nations
- China
In The Last Decade
Linxi Yang
15 papers receiving 540 citations
Linxi Yang's Hit Papers
Peers
Comparison fields: 5 of 41
- Cancer Research 242
- Molecular Biology 449
- Gastroenterology 17
- Oncology 54
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Linxi Yang
This map shows the geographic impact of Linxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxi Yang more than expected).
Fields of papers citing papers by Linxi Yang
This network shows the impact of papers produced by Linxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxi Yang. The network helps show where Linxi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linxi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer Hit paper breakdown → | 2019 | 469 |
| 2 | 2019 | 17 | |
| 3 | 2019 | 12 | |
| 4 | 2022 | 11 | |
| 5 | 2024 | 7 | |
| 6 | 2023 | 5 | |
| 7 | 2021 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2020 | 4 | |
| 10 | Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1. | 2023 | 2 |
| 11 | 2023 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 0 |
About Linxi Yang
Linxi Yang is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 16 papers that have together received 540 indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (9 papers), Metastasis and carcinoma case studies (4 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer Mechanisms and Therapy (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Renal cell carcinoma treatment (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Cancer Research (242 citations), Molecular Biology (449 citations), Gastroenterology (17 citations), Oncology (54 citations) and Pulmonary and Respiratory Medicine (34 citations). Linxi Yang has collaborated with scholars based in China. Frequent co-authors include Ben Yue, Gang Zhao, Ran Cui, Zizhen Zhang, Chenlong Song, Bo Ni, Chun Zhuang, Hui Cao, Wenyi Zhao and Xinli Ma. Their work appears in journals such as Molecular Cancer, Diagnostic Pathology, Gastric Cancer, Cancer Medicine and Journal of Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.